Not sure Port whether Gyrase is quicker to get to market than other drugs.
However if it is one of the drugs on Pfizer's lead list and more advanced than anything else in this space, IMO Pfizer may be willing to pay a larger upfront/royalty to avoid others getting their hands on it. It also helps that we may be in their backyard in the near future :)
melbourne meeting, page-8
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)